169 related articles for article (PubMed ID: 11242180)
21. Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions.
Lilly EA; Shetty KV; Leigh JE; Cheeks C; Fidel PL
Med Mycol; 2005 Sep; 43(6):517-23. PubMed ID: 16323309
[TBL] [Abstract][Full Text] [Related]
22. Alteration of humoral responses to Candida in HIV infection.
Wray D; Felix DH; Cumming CG
Br Dent J; 1990 Apr; 168(8):326-9. PubMed ID: 2185811
[TBL] [Abstract][Full Text] [Related]
23. Relationship between serum and saliva antibodies to Candida and isolation of Candida species from the mucosa of HIV-infected individuals.
Castro G; Martinez R
Mycoses; 2009 May; 52(3):246-50. PubMed ID: 18643885
[TBL] [Abstract][Full Text] [Related]
24. Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis.
Quindós G; Pontón J; Cisterna R
Eur J Clin Microbiol; 1987 Apr; 6(2):142-6. PubMed ID: 3297681
[TBL] [Abstract][Full Text] [Related]
25. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells.
Sweet SP; Cookson S; Challacombe SJ
J Med Microbiol; 1995 Dec; 43(6):452-7. PubMed ID: 7473680
[TBL] [Abstract][Full Text] [Related]
26. Serum and salivary antibodies to a mycobacterial 65-kDa stress protein are elevated in HIV-positive patients and modified by oral candidiasis.
Coogan MM; Challacombe SJ
Oral Microbiol Immunol; 2000 Oct; 15(5):284-9. PubMed ID: 11154418
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.
Myers TA; Leigh JE; Arribas AR; Hager S; Clark R; Lilly E; Fidel PL
Infect Immun; 2003 Feb; 71(2):956-63. PubMed ID: 12540578
[TBL] [Abstract][Full Text] [Related]
28. Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic.
Wulandari EAT; Saraswati H; Adawiyah R; Djauzi S; Wahyuningsih R; Price P
Arch Oral Biol; 2017 Oct; 82():86-91. PubMed ID: 28622549
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
30. Nasal vaccination induces the ability to eliminate Candida colonization without influencing the pre-existing antigen-specific IgE Abs: a possibility for the control of Candida-related atopic dermatitis.
Suenobu N; Kweon MN; Kiyono H
Vaccine; 2002 Jul; 20(23-24):2972-80. PubMed ID: 12126910
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes.
Tavanti A; Pardini G; Campa D; Davini P; Lupetti A; Senesi S
J Clin Microbiol; 2004 Oct; 42(10):4726-34. PubMed ID: 15472333
[TBL] [Abstract][Full Text] [Related]
32. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection.
Sweet SP; Challacombe SJ; Naglik JR
Adv Exp Med Biol; 1995; 371B():1031-4. PubMed ID: 7502746
[No Abstract] [Full Text] [Related]
33. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
34. Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.
Pomarico L; Cerqueira DF; de Araujo Soares RM; de Souza IP; de Araujo Castro GF; Socransky S; Haffajee A; Teles RP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):203-10. PubMed ID: 19615660
[TBL] [Abstract][Full Text] [Related]
35. Immunologic aspects of oral candidiasis.
Challacombe SJ
Oral Surg Oral Med Oral Pathol; 1994 Aug; 78(2):202-10. PubMed ID: 7936590
[TBL] [Abstract][Full Text] [Related]
36. In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients.
Schaller M; Hube B; Ollert MW; Schäfer W; Borg-von Zepelin M; Thoma-Greber E; Korting HC
J Invest Dermatol; 1999 Mar; 112(3):383-6. PubMed ID: 10084319
[TBL] [Abstract][Full Text] [Related]
37. [Differentiation and diagnostic significance of immunoglobulin classes of antibodies against cell wall antigens of yeast and mycelial phase of Candida albicans (author's transl)].
Ansorg R; Gunesch D; Bandelow B; Thomssen R
Mykosen; 1977 May; 20(5):167-77. PubMed ID: 329125
[No Abstract] [Full Text] [Related]
38. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
[TBL] [Abstract][Full Text] [Related]
39. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
[TBL] [Abstract][Full Text] [Related]
40. Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans.
Dong S; Shi H; Cao D; Wang Y; Zhang X; Li Y; Gao X; Wang L
Sci Rep; 2016 Aug; 6():32256. PubMed ID: 27558409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
